Tag: C-CAMP
New breakthrough treatment for sepsis licensed to Dutch spinoff SurvivX by...
Polymicrobial sepsis is a worldwide challenge, with approximately 50 million cases and 11 million sepsis-related deaths worldwide
C-CAMP partners SBI Foundation to launch CoE for Antimicrobial Resistance
The CoE will be under the aegis of the global India AMR Innovation hub or IAIH platform also anchored by C-CAMP & chaired by the Office of the Principal Scientific Adviser
C-CAMP partners Govt of Karnataka to strengthen public health system
Karnataka Health Minister, Dinesh Gundu Rao has announced launch of a C-CAMP partnership with Department of Health and Family Welfare Services, Govt of Karnataka to strengthen the public health system through indigenous, innovative technologies
C-CAMP partners with Capital 2B to foster & invest in early-stage...
This partnership will facilitate seed-stage investment funding of 200-600K USD and capacity building for start-ups having innovative solutions
Two C-CAMP supported startups win top honours at global J&J Innovation...
The startups are Aaarna Therapeutics, a C-CAMP BIRAC funded and incubated company and Qure.AI, supported by C-CAMP’s Digital Health program
C-CAMP receives CSR support from Cytiva to foster early-stage innovations in...
The funds will go into identifying promising early-stage ventures and accelerate their commercialization trajectory
C-CAMP launches 4th edition of CARB-X supported AMR Quest
The quest presents opportunities for funding and commercialization of idea-stage as well as more mature stage innovations
“Innovations played a major role in India’s pandemic response”
Dr Taslimarif Saiyed, CEO and Director, Centre for Cellular and Molecular Platforms (C-CAMP), shares his thoughts on the India’s biotech R&D
C-CAMP InDx launches InDx 2.0 National Diagnostics Catapult
Initiative aims to boost India’s preparedness for current and future pandemics and scale up India’s diagnostics space for infectious diseases including but not limited to COVID-19
CrisprBits develops OmiCrisp, India’s first CRISPR-based SARS-CoV2 test with Omicron detection
OmiCrisp has been developed with support from Centre for Cellular and Molecular Platforms (C-CAMP)-InDx Program